Latigo Biotherapeutics
Clinical trials sponsored by Latigo Biotherapeutics, explained in plain language.
-
New pain drug tested after wisdom tooth removal
Symptom relief CompletedThis study tested whether a single dose of LTG-001 can safely relieve pain after wisdom tooth removal. About 250 adults took the drug or a placebo and reported their pain level over 12 hours. The goal was to see if LTG-001 works better than a dummy pill for short-term pain contro…
Phase: PHASE2 • Sponsor: Latigo Biotherapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New pain drug could cut opioid use after tummy tucks
Symptom relief CompletedThis study tested an experimental drug called LTG-001 for managing pain after a tummy tuck (abdominoplasty). 343 adults took either a high or low dose of LTG-001, a standard painkiller combination, or a placebo. Researchers measured pain relief over 48 hours and tracked how much …
Phase: PHASE2 • Sponsor: Latigo Biotherapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New pain pill LTG-321 enters first human safety tests
Knowledge-focused CompletedThis early-stage study tests an experimental oral drug called LTG-321 in 236 healthy adults aged 18-55. The main goal is to check safety and how the body processes the drug. Researchers will also measure pain tolerance using a cold water test and see if a high-fat meal affects dr…
Phase: PHASE1 • Sponsor: Latigo Biotherapeutics • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Healthy volunteers help test new pain pill absorption
Knowledge-focused CompletedThis study tested two different tablet forms of an experimental pain drug (LTG-001) in 14 healthy adults to see how well each is absorbed. Participants took single doses of each version, and researchers measured drug levels in the blood. The goal was to find which formulation wor…
Phase: PHASE1 • Sponsor: Latigo Biotherapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC